Australia markets closed

Lucid Diagnostics Inc. (LUCD)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.7153+0.0050 (+0.70%)
As of 09:41AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 37.23M
Enterprise value 70.93M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)10.18
Price/book (mrq)2.16
Enterprise value/revenue 23.78
Enterprise value/EBITDA -0.67

Trading information

Stock price history

Beta (5Y monthly) 1.48
52-week change 3-52.67%
S&P500 52-week change 324.71%
52-week high 31.7210
52-week low 30.6300
50-day moving average 30.8516
200-day moving average 31.2051

Share statistics

Avg vol (3-month) 3219.56k
Avg vol (10-day) 3139.44k
Shares outstanding 552.42M
Implied shares outstanding 652.42M
Float 816.43M
% held by insiders 167.38%
% held by institutions 14.01%
Shares short (15 May 2024) 4285.3k
Short ratio (15 May 2024) 41.12
Short % of float (15 May 2024) 41.51%
Short % of shares outstanding (15 May 2024) 40.55%
Shares short (prior month 15 Apr 2024) 4361.37k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,078.12%

Management effectiveness

Return on assets (ttm)-69.23%
Return on equity (ttm)-255.60%

Income statement

Revenue (ttm)2.98M
Revenue per share (ttm)0.07
Quarterly revenue growth (yoy)124.40%
Gross profit (ttm)N/A
EBITDA -42.57M
Net income avi to common (ttm)-54.53M
Diluted EPS (ttm)-1.2600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)26.5M
Total cash per share (mrq)0.53
Total debt (mrq)14.18M
Total debt/equity (mrq)119.20%
Current ratio (mrq)1.38
Book value per share (mrq)-0.69

Cash flow statement

Operating cash flow (ttm)-38.31M
Levered free cash flow (ttm)-26.73M